Stock Market News Today — NYSE, NASDAQ & OTC Headlines

Energy projects, LNG and infrastructure scale plays

Cheniere Partners (CQP) signed an EPC contract with Bechtel for the first phase of the Sabine Pass expansion, issuing a limited notice to proceed. For energy investors, the move shortens the path to incremental export volumes and revenue visibility.

Tamboran (TBN) completed the acquisition of subsidiaries of Falcon Oil & Gas, a step that enlarges its exploration and development footprint; read the transaction notice. Buyers will assess capex needs and near‑term production optionality.

Cemex (CX), Port Tampa Bay and local officials completed a US$36 million terminal expansion to support regional growth. Improved logistics capacity can ease construction-material bottlenecks and support inland demand.

Defense, aerospace and autonomy wins

Elbit Systems (ESLT) won a US$350 million contract for international tank upgrades, underscoring steady aftermarket and upgrade demand.

Red Cat (RCAT) said Blue Ops has ramped into full‑rate production of a U.S.‑built Variant 7, advancing Red Cat’s autonomy stack across air, land and sea; read the production update. Full‑rate production improves revenue visibility for autonomy suppliers and highlights defense supply‑chain maturation.

XTEND (JFB) was selected for the Phase II qualifier of the U.S. Department of Defense’s US$1 billion Drone Dominance Program, a program that can be transformational for defense‑tech revenue profiles.

AeroVironment (AVAV) was awarded a US$20 million contract to advance ceramic materials research for the U.S. Air Force and Space Force, highlighting investment in resilient space and aircraft components.

Biotech breakthroughs and regulatory milestones that could move markets

Altimmune (ALT) reported that pemvidutide produced significant metabolic improvements at 48 weeks in MASH patients in Phase 2b IMPACT data presented at EASL 2026. Positive mid‑stage liver results can materially alter development timelines and commercial potential for metabolic/NASH franchises.

Ionis Pharmaceuticals (IONS) partner GSK announced bepirovirsen produced unprecedented functional cure rates for chronic hepatitis B in trials — a potential paradigm shift for infectious‑disease therapeutics and platform biotech valuations.

Immunome (IMMP) reported systemic immune activation with eftilagimod alfa associated with a statistically significant increase in overall survival in late‑stage cancer patients — a clinical signal that may drive re‑ratings in immune‑oncology plays.

RenovoRx (RNXT) received FDA orphan drug designation for oxaliplatin in pancreatic cancer, a regulatory incentive that can extend exclusivity and support valuation for niche oncology drugs.

MiNK Therapeutics (INKT) announced the first patient dosed in a randomized Phase 2 trial of agenT‑797 for acute lung injury; enrollment milestones paired with safety readouts can de‑risk timelines.

Notable earnings, consumer spend and financial updates

• Futu (FUTU) reported Q1 revenues up 25% YoY to US$746.9 million — investors will parse user growth and margin leverage in fintech earnings.
• XPENG (XPEV) released Q1 2026 results showing a gross margin sustained at 20.6% and highlighted accelerating physical AI mass production and international commercialization. Margin resilience at scale is a key metric for EV investors assessing unit economics.
• Newegg (NEGG) announced first‑quarter 2026 results; the e‑commerce player’s topline and margin trends will be watched for consumer demand signals in electronics retail — see the release.
• Toro (TORO) reported net income of US$0.5 million for Q1, an outcome investors will weigh against seasonal cycles and aftermarket demand; read the statement.

Retail partnerships, consumer products and distribution moves

DoorDash (DASH) teamed with Dollar Tree (DLTR) to bring on‑demand shopping to Dollar Tree stores; read the partnership announcement. The tie‑up could accelerate same‑day convenience strategies and incremental delivery revenue.

Mondelez (MDLZ) rolled out a new branding and packaging for NEWTONS, introducing the iconic bar to a new generation; see the product launch. Brand refreshes can spark renewed retail placement and promotional activity.

Curiosity Stream (CURI) launched on the Apple TV App in Mexico, expanding distribution reach into a key Latin American market; read the distribution note. Platform rollouts help subscription video services scale international paid‑user metrics.

AI, semiconductors, quantum and cybersecurity

Lattice Semiconductor (LSCC) and ASPEED Technology announced a strategic partnership to advance datacenter management control; read the joint statement. Control‑plane silicon remains a tight niche as hyperscalers optimize infrastructure.

Western Digital (WDC) was highlighted in a piece calling the company a new front‑runner in the rare‑earth race, underscoring strategic materials and supply‑chain positioning for storage and advanced components. Investors will watch resource exposure and vertical integration signals.

Check Point Software (CHKP) launched an Agentic Exposure Validation product to counter frontier AI models capable of autonomous exploitation. Vendor responses to agentic threats are becoming a new revenue axis for cybersecurity vendors.

CrowdStrike (CRWD) expanded Project QuiltWorks with cyber‑insurance leaders to tackle financial exposure from frontier AI risk, linking cybersecurity products to insurance markets.

Lab tools, diagnostics and R&D support

Thermo Fisher Scientific (TMO) unveiled next‑generation innovations at ASMS 2026 aimed at accelerating drug discovery; see the event write‑up. Product cycles at large lab suppliers often presage spending for biopharma customers.

Illumina (ILMN) introduced the first distributed whole‑genome sequencing solution targeting highly sensitive MRD research — a step that could broaden adoption of genomics in oncology monitoring; read the product announcement.

AI, enterprise software and platform expansions

Tempus (TEM) expanded its Next platform to deliver real‑time clinical intelligence aimed at closing critical care gaps across oncology. Platform enhancements that speed clinical decisioning can affect adoption curves with health systems.

Digital Brands Group (DBGI) advanced its enterprise AI strategy through a collaboration with a global outdoor apparel brand; read the update. Enterprise AI partnerships often presage recurring revenue opportunities.